Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Announces New Nanotechnology Patent

NEW YORK, Dec. 3 (GenomeWeb News) - Nanogen announced today it has received a new  patent covering the assembly of nucleic acid-based nanotechnology structures.


The patent, No. 6,652,808, was granted Nov. 25 and is entitled "Methods for the Electronic Assembly and Fabrication of Devices." It details methods to use an electric field to assist in self-assembly of programmable nucleic acids and structures that are building blocks for "molecular electronic and photonic mechanisms," as well as nanostructures, and means to communicate between nanostructures. It also describes how these nanostructures can be assembled.


"The technology described by Nanogen's new patent may provide a technological foundation for the effective use of nanocomponents in many diverse applications," Howard Birndorf, Nanogen chairman and CEO, said in a statement.


The company intends to license out its nanotechnology patents or develop partnerships for their use, Birndorf said.


This is the ninth patent that Nanogen has received in 2003, the company said, and it has received 56 US patents in total.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.